酮发生
非酒精性脂肪肝
生酮饮食
医学
酮症
热卡限制
胰岛素抵抗
内科学
脂肪肝
碳水化合物
肥胖
减肥
代谢综合征
内分泌学
脂肪变性
胰岛素
胃肠病学
体质指数
脂肪组织
肝病
2型糖尿病
生理学
糖尿病
超重
脂肪性肝炎
疾病
新陈代谢
酮体
癫痫
精神科
作者
Renata Risi,Rossella Tozzi,Mikiko Watanabe
出处
期刊:Current Opinion in Clinical Nutrition and Metabolic Care
[Ovid Technologies (Wolters Kluwer)]
日期:2021-07-01
卷期号:24 (4): 349-353
被引量:4
标识
DOI:10.1097/mco.0000000000000762
摘要
The low fat diet (LFD) is currently the first choice to treat nonalcoholic fatty liver disease (NAFLD) alongside with physical activity. However, low carbohydrate diets (LCDs) and ketogenic diets have gained attention lately, thanks to their favourable impact in reducing intrahepatic triglyceride content. We therefore aimed at providing an update on recent evidence evaluating the hepatoprotective effects of such dietary interventions.Novel findings confirmed previous evidence by showing beneficial effects on liver fat content reduction for both LFDs and LCDs. The further restriction of carbohydrates to less than 50 g/day, usually leading to ketosis, confirmed to produce an improvement in NAFLD, with very low-calorie ketogenic diets possibly proving particularly beneficial thanks to the significant weight loss that can be obtained.Most of the latest evidence shows that carbohydrate restriction plays a fundamental role in the modulation of lipid metabolism leading to similar efficacy in improving NAFLD compared with LFDs. The hepatoprotective role of carbohydrate restriction appears to be boosted when ketogenesis is induced, when the total calorie intake is extremely reduced, or, possibly, when dietary interventions have reduced content in free sugars, making such interventions valuable tools to deal with NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI